BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24957018)

  • 1. Cocoa extracts reduce oligomerization of amyloid-β: implications for cognitive improvement in Alzheimer's disease.
    Wang J; Varghese M; Ono K; Yamada M; Levine S; Tzavaras N; Gong B; Hurst WJ; Blitzer RD; Pasinetti GM
    J Alzheimers Dis; 2014; 41(2):643-50. PubMed ID: 24957018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for Development of New Standardized Forms of Cocoa Breeds and Cocoa Extract Processing for the Prevention of Alzheimer's Disease: Role of Cocoa in Promotion of Cognitive Resilience and Healthy Brain Aging.
    Dubner L; Wang J; Ho L; Ward L; Pasinetti GM
    J Alzheimers Dis; 2015; 48(4):879-89. PubMed ID: 26402120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
    Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
    Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.
    Takamura Y; Ono K; Matsumoto J; Yamada M; Nishijo H
    Neurobiol Aging; 2014 Mar; 35(3):532-6. PubMed ID: 24112791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thymol on amyloid-β-induced impairments in hippocampal synaptic plasticity in rats fed a high-fat diet.
    Asadbegi M; Komaki A; Salehi I; Yaghmaei P; Ebrahim-Habibi A; Shahidi S; Sarihi A; Soleimani Asl S; Golipoor Z
    Brain Res Bull; 2018 Mar; 137():338-350. PubMed ID: 29339105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.
    Zolezzi JM; Lindsay CB; Serrano FG; Ureta RC; Theoduloz C; Schmeda-Hirschmann G; Inestrosa NC
    J Alzheimers Dis; 2018; 63(2):705-723. PubMed ID: 29660932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of centipedegrass against Aβ oligomerization and Aβ-mediated cell death in PC12 cells.
    Song Y; Kim HD; Lee MK; Kim MK; Kang SN; Ko YG; Won CK; Kim GS; Lee SS; Bai HW; Chung BY; Cho JH
    Pharm Biol; 2015; 53(9):1260-6. PubMed ID: 25853960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
    Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
    Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
    Bisel BE; Henkins KM; Parfitt KD
    Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
    Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of GluN2B subunit containing N-methyl-d-aspartate (NMDA) receptors in mediating the acute and chronic synaptotoxic effects of oligomeric amyloid-beta (Aβ) in murine models of Alzheimer's disease (AD).
    Rammes G; Mattusch C; Wulff M; Seeser F; Kreuzer M; Zhu K; Deussing JM; Herms J; Parsons CG
    Neuropharmacology; 2017 Sep; 123():100-115. PubMed ID: 28174113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal pyroglutamate formation of Aβ38 and Aβ40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation.
    Schlenzig D; Rönicke R; Cynis H; Ludwig HH; Scheel E; Reymann K; Saido T; Hause G; Schilling S; Demuth HU
    J Neurochem; 2012 Jun; 121(5):774-84. PubMed ID: 22375951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
    Zhang JF; Qi JS; Qiao JT
    Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.